Pancreatic Cancer Action

From Wikipedia, the free encyclopedia
Pancreatic Cancer Action
Type Charitable organisation
Registration No. England and Wales: 1137689
Founded 2009 (2009)
Founder(s) Ali Stunt
Headquarters
  • Chiltlee Manor, Haslemere Road, Liphook, Hampshire, GU30 7AZ
Area served United Kingdom
Focus(es) pancreatic cancer, Cancer research, Health policy
Mission TO IMPROVE SURVIVAL FOR PANCREATIC CANCER PATIENTS THROUGH EARLIER DIAGNOSIS
Motto Tackling pancreatic cancer head on
Website www.pancreaticcanceraction.org

Pancreatic Cancer Action is a not-for-profit organisation based in the UK whose mission it is to raise awareness of pancreatic cancer

Founded by Ali Stunt, who is herself a rare survivor of the disease,[1] Pancreatic Cancer Action is dedicated to saving lives. The 5-year survival rate for pancreatic cancer is only around 3% - this number has not improved in over 40 years.

Pancreatic cancer is the 5th commonest cause of cancer death in the UK yet receives only 1% of research funding.[2] Only 10% of patients with a diagnosis for pancreatic cancer are able to have potentially curative surgery.[3][4]

  • Mission: To change pancreatic cancer survival numbers
  • Focus: To improve early detection statistics
  • Approach: To increase awareness of pancreatic cancer to the public, the medical community and Government

One focus is the annual UK Pancreatic Cancer Awareness Month held in November each year.

Having been involved in setting up the very first Pancreatic Cancer Awareness Week in 2009, Ali Stunt decided it was time to step up the levels of awareness for pancreatic cancer and so founded Pancreatic Cancer Action to do just that.

Along with Stunt, Pancreatic Cancer Action has the support of many leading clinicians and researchers in the pancreatic cancer arena along with others whose lives have been touched by pancreatic cancer in some way.

The team

  • Alison Stunt - Founder & CEO
  • Phil Stunt - Chair
  • Helen Matthews - Secretary & Fundraising
  • Jane McCue - Treasurer
  • Charlotte Maude - Marketing/PR
  • Neville Menezes - Consultant Pancreatic Surgeon
  • Carolyn Scott - Medical Liaison

Medical advisors

  • Mr Ross Carter - Glasgow Royal Infirmary (surgical)
  • Dr. Seb Cummins - Royal Surrey County Hospital, Guildford (clinical oncology)
  • Mr Hemant Kocher - Barts and London (surgical)
  • Mr Neville Menezes - Royal Surrey County Hospital, Guildford (surgical)
  • Dr. Gary Middleton - Royal Surrey County Hospital, Guildford (medical oncology)
  • Dr. Kevin Shotliff - Chelsea & Westminster Hospital and Brompton Hospital. Royal Marsden Hospital (endocrinology)

Patrons

References

  1. Stunt, Ali (August 30, 2012). "It's official – I'm now one of the 3% who survive pancreatic cancer". Pancreatic Cancer Action. Retrieved February 24, 2013. 
  2. "Five year analysis of the national cancer research database, 2002-2006". National Cancer Research Institute. 2008.
  3. White et al., (1999) in Sultana et al. (2007). "Systematic review, including meta-analysis, on the management of locally advanced pancreatic cancer using radiation/combined modal therapy". British Journal of Cancer 96: 1183-1190.
  4. "UK pancreatic cancer prognosis and survival rates". Pancreatic Cancer Action. Retrieved February 24, 2013. 

External links

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.